Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.48 Billion | USD 10.59 Billion | 8.75% | 2022 |
The global next generation blood gas monitors system market size was worth around $ 5.48 billion in 2022 and is predicted to grow to around $ 10.59 billion by 2030 with a compound annual growth rate (CAGR) of roughly 8.75% between 2023 and 2030.
The report analyzes the global next generation blood gas monitors system market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the next generation blood gas monitors system industry.
The next generation blood gas monitors are the devices that are used for observing the level of carbon dioxide tension, arterial oxygen tension, and acidity. By checking these parameters diagnosis of the disease becomes easy. The condition may be a shock, pulmonary disorder, overdose of certain drug, etc. The next generation blood gas monitors are fundamental devices that are present in the CCU and ICU rooms. There are many technological advancements done in this field.
The major factors that are favoring the growth of the next generation blood gas monitors are the increased rate of the hospital admissions, the growing number of the geriatric population, and the rise in the prevalence of the chronic diseases. The other factors that are influencing the growth of the next generation blood gas monitors systems market in the coming years are the increasing healthcare expenditure and the development of the advanced technologies. The factors that are affecting the market growth in a negative way are the stringent regulatory protocols in some of the nations and the rise in the cost of the point of care devices.
Report Attributes | Report Details |
---|---|
Report Name | Next Generation Blood Gas Monitors System Market Research Report |
Market Size in 2022 | USD 5.48 Billion |
Market Forecast in 2028 | USD 10.59 Billion |
Growth Rate | CAGR of 8.75% |
Number of Pages | 210 |
Key Companies Covered | Bayer, Convergent Technologies, Alere, Inc., Roche Diagnostics, Samsung Medison, Nova Stat, Alere, Medica, Radiometer Medical, Abbott Point of Care Inc., Nova Biomedical, Siemens Healthcare, Erba, Edan Instruments, and Dalko Diagnostics |
Segments Covered | By Product Type, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global market for the next generation blood gas monitors system is fragmented into its product type, end user, and application. On the basis of the product type, the market is segregated into portable and bench top. On the basis of end user, the market is categorized into hospitals, clinical laboratories, cardiac centers, and others. On the basis of application, the market is divided into combined and single next generation blood gas monitors.
The key market players that are involved in the next generation blood gas monitors system market include Bayer, Convergent Technologies, Alere, Inc., Roche Diagnostics, Samsung Medison, Nova Stat, Alere, Medica, Radiometer Medical, Abbott Point of Care Inc., Nova Biomedical, Siemens Healthcare, Erba, Edan Instruments, and Dalko Diagnostics.
The geographical diversification of the global next generation blood gas monitors system market includes Asia Pacific, North America, the Middle East and Africa, Eastern Europe, Latin America, and Western European regions. The region that is leading the next generation blood gas monitors system market is North America. Europe is following North America in terms of market growth. The factors that are contributing to the market growth in these regions are the increased technological advancements, highly developed healthcare infrastructure, and the increased number of the market players.
Increasing number of the product innovations that are made in this field is also supporting the growth of the market. It has been observed that the next generation blood gas monitors that are available in the regions of North America and Western Europe have the capability to incorporate with the EMR system of the hospital which helps in improving the work flow. The market in Asia Pacific will grow at a significant rate due to the increasing aging population and the rise in the cases of chronic diseases.
By Product Type
By End User
Next Generation Blood Gas Monitors System Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
The next generation blood gas monitors are the devices that are used for observing the level of carbon dioxide tension, arterial oxygen tension, and acidity. By checking these parameters diagnosis of the disease becomes easy.
The major factors that are favoring the growth of the next generation blood gas monitors are the increased rate of the hospital admissions, the growing number of the geriatric population, and the rise in the prevalence of the chronic diseases.
The global next generation blood gas monitors system market size was worth around $ 5.48 billion in 2022 and is predicted to grow to around $ 10.59 billion by 2030.
The next generation blood gas monitors system market is expected to grow at a CAGR of 8.75% during the forecast period.
The geographical diversification of the global next generation blood gas monitors system market includes Asia Pacific, North America, the Middle East and Africa, Eastern Europe, Latin America, and Western European regions. The region that is leading the next generation blood gas monitors system market is North America. Europe is following North America in terms of market growth.
The key market players that are involved in the next generation blood gas monitors system market include Bayer, Convergent Technologies, Alere, Inc., Roche Diagnostics, Samsung Medison, Nova Stat, Alere, Medica, Radiometer Medical, Abbott Point of Care Inc., Nova Biomedical, Siemens Healthcare, Erba, Edan Instruments, and Dalko Diagnostics.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed